Mutations overlapping with those in cancer localize to the SMARCA4 ATP binding pocket and nucleosomal DNA-binding residues, the SMARCB1-CTD, and the SMARCA4-BAF core module entry point (Fig. 5b and Extended Data Fig. 5f). This evidence concerns the gene SMARCA4 and cancer.